nach oben

Endocrine

Erschienen in:

03.09.2019 | Review

Diagnosis and treatment of hypothyroidism in the elderly

verfasst von: Leonidas H. Duntas, Paul Michael Yen

Erschienen in: Endocrine | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

The global population is aging with millions of people today living into their 90 s. Thyroid disease, particularly hypothyroidism, is widespread among all age groups, and it is expected to steadily increase as the population gets older. Clinical diagnosis of hypothyroidism is challenging, as the TSH reference range needs to be evaluated according to age, while evaluation of TSH levels must also take into account body weight and other variants such as polypharmacy, comorbidities, and general health condition. Since thyroid hormone has a potent regulatory effect on cholesterol metabolism, the possibility of thyroid dysfunction should be considered in cases of unexplained dyslipidemia. Once hypothyroidism has been confirmed, treatment requires caution, frequent cardiovascular monitoring, and individualized (precision) medicine. Treatment of subclinical hypothyroidism (SCH) in the elderly should be undertaken with care, guided by age and the degree of SCH: a TSH higher than 10 mU/l seems a reasonable threshold, though it should be regularly re-evaluated, while the LT4 dose needs to be tailored, taking into account the patient’s health condition and the potential presence of dyslipidemia as well as other metabolic derangements.

Population Division. U.S. Census Bureau, The Census Bureau on prospects for US population growth in the twenty-first century. Popul. Dev. Rev. 26, 197–200 (2000). https://doi.org/10.1111/j.1728-4457.2000.00197.x CrossRef

W. Lutz, W. Sanderson, S. Scherbov, The coming acceleration of global population ageing. Nature 451, 716–719 (2008). https://doi.org/10.1038/nature06516 CrossRefPubMed

P. Laurberg, S. Andersen, I. Bülow Pedersen, A. Carle, Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment. Drugs Aging 22, 23–38 (2005). https://doi.org/10.2165/00002512-200522010-00002 CrossRefPubMed

J.V. Hennessey, R. Espaillat, Diagnosis and management of subclinical hypothyroidism in elderly adults: a review of the literature. J. Am. Geriatr. Soc. 63, 1663–1673 (2015). https://doi.org/10.1111/jgs.13532 CrossRefPubMed

W.M. Tunbridge, D.C. Evered, R. Hall, D. Appleton, M. Brewis, F. Clark, J.G. Evans, E. Young, T. Bird, P.A. Smith, The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. 7, 481–493 (1977)CrossRef

J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002). https://doi.org/10.1210/jcem.87.2.8182 CrossRefPubMed

T. Vadiveloo, P.T. Donnan, M.J. Murphy, G.P. Leese, Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: the thyroid epidemiology, audit, and research study (TEARS). J. Clin. Endocrinol. Metab. 98, 1147–1153 (2013). https://doi.org/10.1210/jc.2012-3191 CrossRefPubMed

O. Leng, S. Razvi, Hypothyroidism in the older population. Thyroid Res. 8(12), 22 (2019). https://doi.org/10.1186/s13044-019-0063-3 CrossRef

X. Zhai, L. Zhang, L. Chen, X. Lian, C. Liu, B. Shi, L. Shi, N. Tong, S. Wang et al. An age-specific serum thyrotropin reference range for the diagnosis of thyroid diseases in older adults: a cross-sectional survey in China. Thyroid (2018). https://doi.org/10.1089/thy.2017.0715

10.

L.H. Duntas, Thyroid function in aging: a discerning approach. Rejuvenation Res 21, 22–28 (2018). https://doi.org/10.1089/rej.2017.1991 CrossRefPubMed

11.

C.D. Smith, R. Grondin, W. LeMaster, B. Martin, B.T. Gold, K.B. Ain, Reversible cognitive, motor, and driving impairments in severe hypothyroidism. Thyroid 25, 28–36 (2015). https://doi.org/10.1089/thy.2014.0371 CrossRefPubMed

12.

R. Gourmelon, S. Donadio-Andréi, K. Chikh, M. Rabilloud, E. Kuczewski, A.S. Gauchez et al. Subclinical hypothyroidism: is it really subclinical with aging? Aging Dis. 10, 520–529 (2019). https://doi.org/10.14336/AD.2018.0817 CrossRefPubMedPubMedCentral

13.

D. Strich, G. Karavani, S. Edri, D. Gillis, TSH enhancement of FT4 to FT3 conversion is age dependent. Eur. J. Endocrinol. 175, 49–54 (2016). https://doi.org/10.1530/EJE-16-0007 CrossRefPubMed

14.

J.D. Veldhuis, Changes in pituitary function with aging and implications for patient care. Nat. Rev. Endocrinol. 9, 205–215. https://doi.org/10.1038/nrendo.2013.38

15.

F. Monzani, P. Del Guerra, N. Caraccio, L. Del Corso, A. Casolaro, S. Mariotti, F. Pentimone, F. Age-related, modifications in the regulation of the hypothalamic-pituitary-thyroid axis. Horm. Res. 46, 107–1012 (1996). https://doi.org/10.1159/000185005 CrossRefPubMed

16.

S. Mariotti, G. Barbesino, P. Caturegli, L. Bartalena, P. Sansoni, F. Fagnoni, D. Monti, U. Fagiolo, C. Franceschi, A. Pinchera, Complex alteration of thyroid function in healthy centenarians. J. Clin. Endocrinol. Metab. 77, 1130–1134 (1993). https://doi.org/10.1210/jcem.77.5.8077303 CrossRefPubMed

17.

S. Volpato, J.M. Guralnik, L.P. Fried, A.T. Remaley, A.R. Cappola, L.J. Launer, Serum thyroxine level and cognitive decline in euthyroid older women. Neurology 58, 1055–1061 (2002). https://doi.org/10.1212/wnl.58.7.1055 CrossRefPubMed

18.

A. Carlé, P. Laurberg, I.B. Pedersen, H. Perrild, L. Ovesen, L.B. Rasmussen, T. Jorgensen, N. Knudsen, Age modifies the pituitary TSH response to thyroid failure. Thyroid 17, 139–144 (2007). https://doi.org/10.1089/thy.2006.0191 CrossRefPubMed

19.

A.P. Bremner, P. Feddema, P.J. Leedman, S.J. Brown, J.P. Beilby, E.M. Lim, S.G. Wilson, P.C. O’Lear, J.P. Walsh, Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J. Clin. Endocrinol. Metab. 97, 1554–1562 (2012). https://doi.org/10.1210/jc.2011-3020 CrossRefPubMed

20.

P.S. Hansen, T.H. Brix, T.I. Sørensen, K.O. Kyvik, L. Hegedüs, Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. J. Clin. Endocrinol. Metab. 89, 1181–1187 (2004). https://doi.org/10.1210/jc.2003-031641 CrossRefPubMed

21.

J.V. Hennessey, R. Espaillat, Subclinical hypothyroidism: a historical view and shifting prevalence. Int. J. Clin. Pract. 69, 771–782 (2015). https://doi.org/10.1111/ijcp.12619 CrossRefPubMedPubMedCentral

22.

G. Atzmon, N. Barzilai, J.G. Hollowell, M.I. Surks, I. Gabriely, Extreme longevity is associated with increased serum thyrotropin. J. Clin. Endocrinol. Metab. 94, 1251–1254 (2009). https://doi.org/10.1210/jc.2008-2325 CrossRefPubMedPubMedCentral

23.

J. Gussekloo, E. van Exel, A.J. de Craen, A.E. Meinders, M. Froehlich, R.G. Westendorp, Thyroid status, disability and cognitive function, and survival in old age. JAMA 292, 2591–2599 (2004). https://doi.org/10.1001/jama.292.21.2591 CrossRefPubMed

24.

N.A. van Vliet, E. van der Spoel, M. Beekman, P.E. Slagboom, G.J. Blauw, J. Gusseklo, R.G.J. Westendorp, D. van Heemst, Thyroid status and mortality in nonagenarians from long-lived families and the general population. Aging 9, 2223–2234 (2017). https://doi.org/10.18632/aging.101310 CrossRefPubMedPubMedCentral

25.

M.P. Rozing, J.J. Houwing-Duistermaat, P.E. Slagboom, M. Beekman, M. Froelich, A.J. de Craen, Familial longevity is associated with decreased thyroid function. J. Clin. Endocrinol. Metab. 95, 4979–4984 (2010). https://doi.org/10.1210/jc.2010-0875 CrossRefPubMed

26.

R. Over, S. Mannan, H. Nsouli-Maktabi, K.D. Burman, J. Jonklaas, Age and thyrotropin response to hypothyroxinemia. J. Clin. Endocrinol. Metab. 95, 3675–3683 (2010). https://doi.org/10.1210/jc.2010-0281 CrossRefPubMedPubMedCentral

27.

L.H. Duntas, G.A. Brenta, A renewed focus on the association between thyroid hormones and lipid metabolism. Front. Endocrinol. 9, 511 (2018). https://doi.org/10.3389/fendo.2018.00511 CrossRef

28.

G.A. Sigal, T.M. Tavoni, B.M.O. Silva, R. Kalil Filho, L.G. Brandão, R.C. Maranhão, Effects of short-term hypothyroidism on the lipid transfer to high-density lipoprotein and other parameters related to lipoprotein metabolism in patients submitted to thyroidectomy for thyroid cancer. Thyroid 29, 53–58 (2019). https://doi.org/10.1089/thy.2018.0190 CrossRefPubMed

29.

T. Tagami, H. Kimura, S. Ohtani, T. Tanaka, T. Tanaka, S. Hata, M. Saito, Y. Miyazaki, R. Araki, M. Tanaka, K. Yonezawa, M. Sawamura, T. Ise, A. Ogo, T. Shimbo, A. Shimatsu, M. Naruse; PHPH study group, Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia. Endocr. J. 58, 449–4457 (2011)CrossRefPubMed

30.

P.N. Taylor, D. Albrecht, A. Scholz, G. Gutierrez-Buey, J.H. Lazarus, C.M. Dayan, O.E. Okosieme, Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14, 301–316 (2018). https://doi.org/10.1038/nrendo.2018.18 CrossRefPubMed

31.

B.O. Asvold, L.J. Vatten, T.I. Nilsen, T. Bjoro, The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur. J. Endocrinol. 156, 181–186 (2007). https://doi.org/10.1530/eje.1.02333 CrossRefPubMed

32.

D.L. Willard, A.M. Leung, E.N. Pearce, Thyroid function testing in patients with newly diagnosed hyperlipidemia. JAMA Intern. Med. 174, 287–289 (2014). https://doi.org/10.1001/jamainternmed.2013.12188 CrossRefPubMedPubMedCentral

33.

L.H. Duntas, L. Wartofsky, Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid 17, 1075–1084 (2007). https://doi.org/10.1089/thy.2007.0116 CrossRefPubMed

34.

V. Arnao, A. Tuttolomondo, M. Daidone, A. Pinto, Lipoproteins in atherosclerosis process. Curr. Med. Chem. 26, 1525–1543 (2019). https://doi.org/10.2174/0929867326666190516103953 CrossRefPubMed

35.

J. Pihlajamaki, T. Boes, E.Y. Kim, F. Dearie, B.W. Kim, J. Schroeder, E. Mun, I. Nasser, P.J. Park, A.C. Bianco, A.B. Goldfine, M.E. Patti, Thyroid hormone-related regulation of gene expression in human fatty liver. J. Clin. Endocrinol. Metab. 94, 3521–3529 (2009). https://doi.org/10.1210/jc.2009-0212 CrossRefPubMedPubMedCentral

36.

R.A. Sinha, S.H. You, J. Zhou, M.M. Siddique, B.H. Bay, X. Zhu, M.L. Privalsky, S.Y. Cheng, R.D. Stevens, S.A. Summers, C.B. Newgard, M.A. Lazar, P.M. Yen, Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J. Clin. Investig. 122, 2428–2438 (2012). https://doi.org/10.1172/JCI60580 CrossRefPubMed

37.

J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi, D.S. Cooper, B.W. Kim, R.P. Peeters, M.S. Rosenthal, A.M. Sawka, Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 24, 1670–1751 (2014). https://doi.org/10.1089/thy.2014.0028 CrossRefPubMedPubMedCentral

38.

D.S. Cooper, Thyroid disease in the oldest old: the exception to the rule. JAMA 292, 2651–2654 (2004). https://doi.org/10.1001/jama.292.21.2651. CrossRefPubMed

39.

L.L. Somwaru, A.M. Arnold, N. Joshi, L.P. Fried, A.R. Cappola, High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J. Clin. Endocrinol. Metab. 94, 1342–1345 (2009). https://doi.org/10.1210/jc.2008-1696 CrossRefPubMedPubMedCentral

40.

H.M. Robertson, A.K. Narayanaswamy, O. Pereira, S.A. Copland, R. Herriot, A.W. McKinlay, J.S. Bevan, P. Abraham, Factors contributing to high levothyroxine doses in primary hypothyroidism: an interventional audit of a large community database. Thyroid 24, 1765–1771 (2014). https://doi.org/10.1089/thy.2013.0661 CrossRefPubMed

41.

A. Akirov, H. Gimbel, A. Grossman, T. Shochat, I. Shimon, Elevated TSH in adults treated for hypothyroidism is associated with increased mortality. Eur. J. Endocrinol. 176, 57–66 (2017). https://doi.org/10.1530/EJE-16-0708 CrossRefPubMed

42.

L.H. Duntas, G. Brenta, Thyroid hormones: a potential ally to LDL-cholesterol-lowering agents. Horm. (Athens) 15, 500–510 (2016). https://doi.org/10.14310/horm.2002.1707 CrossRef

43.

B. Biondi, A.R. Cappola, D.S. Cooper, Subclinical Hypothyroidism: a review. JAMA 322, 153–160 (2019). https://doi.org/10.1001/jama.2019.9052 CrossRefPubMed

44.

B. Biondi, D.S. Cooper, The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 29, 76–131 (2008). https://doi.org/10.1210/er.2006-0043 CrossRefPubMed

45.

D.S. Cooper, B. Biondi, Subclinical thyroid disease. Lancet 379, 1142–1154 (2012). https://doi.org/10.1016/S0140-6736(11)60276-6 CrossRefPubMed

46.

L.L. Somwaru, C.M. Rariy, A.M. Arnold, A.R. Cappola, The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J. Clin. Endocrinol. Metab. 97, 1962–1969 (2012). https://doi.org/10.1210/jc.2011-3047 CrossRefPubMedPubMedCentral

47.

M.R. Blum, B. Gencer, L. Adam, M. Feller, T.H. Collet, B.R. da Costa, E. Moutzouri, J. Dopheide, M. Depairon, G.P. Sykiotis, P. Kearney, J. Gussekloo, R. Westendorp, D.J. Stott, D.C. Bauer, N. Rodondi, Impact of thyroid hormone therapy on atherosclerosis in the elderly with subclinical hypothyroidism: a randomized trial. J. Clin. Endocrinol. Metab. 103, 2988–2997 (2018). https://doi.org/10.1210/jc.2018-00279 CrossRefPubMed

48.

V.S. Virgini, L.W. Wijsman, N. Rodondi, D.C. Bauer, P.M. Kearney, J. Gussekloo, W.P. den Elzen, J.W. Jukema, R.G. Westendorp, I. Ford, D.J. Stott, S.P. Mooijaart, PROSPER study group: subclinical thyroid dysfunction and functional capacity among elderly. Thyroid 24, 208–214 (2014). https://doi.org/10.1089/thy.2013.0071 CrossRefPubMedPubMedCentral

49.

A. Grossman, A. Weiss, N. Koren-Morag, I. Shimon, Y. Beloosesky, J. Meyerovitch, Subclinical thyroid disease and mortality in the elderly: a retrospective cohort study. Am. J. Med. 129, 423–430 (2016). https://doi.org/10.1016/j.amjmed.2015.11.027. CrossRefPubMed

50.

D.J. Stott, N. Rodondi, P.M. Kearney, I. Ford, R.G.J. Westendorp, S.P. Mooijaart et al. Trust study group. thyroid hormone therapy for older adults with subclinical hypothyroidism. N. Engl. J. Med. 376, 2534–2544 (2017). https://doi.org/10.1056/NEJMoa1603825 CrossRefPubMed

51.

N.A. van Vliet, R. Noordam, D. van Heemst, Thyroid hormone therapy for older adults with subclinical hypothyroidism. N. Engl. J. Med. 377, e20 (2017). https://doi.org/10.1056/NEJMc1709989 CrossRefPubMed

52.

A. Grossman, I. Feldhamer, J. Meyerovitch, Treatment with levothyroxine in subclinical hypothyroidism is associated with increased mortality in the elderly. Eur. J. Intern. Med. 50, 65–68 (2018). https://doi.org/10.1016/j.ejim.2017.11.010 CrossRefPubMed

53.

E. Bruinstroop, R. Dalan, Y. Cao, Y.M. Bee, K. Chandran, L.W. Cho, S.B. Soh, E.K. Teo, S.A. Toh, M.K.S. Leow, R.A. Sinha, S.A. Sadananthan, N. Michael, H.M. Stapleton, C. Leung, P.W. Angus, S.K. Patel, L.M. Burrell, S.C. Lim, C.F. Sum, S.S. Velan, P.M. Yen, Low-dose levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLD. J. Clin. Endocrinol. Metab. 103, 2698–2706 (2018). https://doi.org/10.1210/jc.2018-00475 CrossRefPubMed

54.

R.S. Du Puy, I. Postmus, D.J. Stott, M.R. Blum, R.K.E. Poortvliet, W.P.J. Den Elzen, R.P. Peeters, Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over. BMC Endocr. Disord. 18, 67 (2018). https://doi.org/10.1186/s12902-018-0285-8 CrossRefPubMedPubMedCentral

55.

S.H. Pearce, G. Brabant, L.H. Duntas, F. Monzani, R.P. Peeters, S. Razvi, J.L. Wemeau, 2013 ETA guideline: management of subclinical hypothyroidism. Eur. Thyroid J. 2, 215–228 (2013). https://doi.org/10.1159/000356507 CrossRefPubMedPubMedCentral

56.

J. Jonklaas, S. Razvi, Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers. Lancet Diabetes. Endocrinol. 7, 473–483 (2019). https://doi.org/10.1016/S2213-8587(18)30371-1 CrossRefPubMed

Titel: Diagnosis and treatment of hypothyroidism in the elderly
verfasst von: Leonidas H. Duntas
Paul Michael Yen
Publikationsdatum: 03.09.2019
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 1/2019
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-019-02067-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism

The isolation of thyroxine (T4), the discovery of 3,5,3’-triiodothyronine (T3), and the identification of the deiodinases that generate T3 from T4: An historical review

Thyroxine and treatment of hypothyroidism: seven decades of experience

Thyroid hormone therapy: past, present, and future

Novel thyroid hormones